A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Lyell Immunopharma, Inc.
Ohio State University Comprehensive Cancer Center
Roswell Park Cancer Institute
AIDS Malignancy Consortium
St. Jude Children's Research Hospital
Genmab
Genmab
Artiva Biotherapeutics, Inc.
Acerta Pharma BV
Baylor College of Medicine
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
University of Chicago
Malaghan Institute of Medical Research
Case Comprehensive Cancer Center
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
Essen Biotech
M.D. Anderson Cancer Center
Imugene Limited
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
University of California, San Francisco
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Sana Biotechnology
Massachusetts General Hospital
Case Comprehensive Cancer Center
University of Arizona
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Celgene
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Sana Biotechnology
National Institutes of Health Clinical Center (CC)
Universität des Saarlandes
St. Jude Children's Research Hospital
Acepodia Biotech, Inc.
University Hospital Southampton NHS Foundation Trust
Chinese PLA General Hospital
University of Miami
Massachusetts General Hospital
Roswell Park Cancer Institute